InMed Pharmaceuticals Stock Forecast - Naive Prediction
| INM Stock | USD 5.26 0.11 2.14% |
The Naive Prediction forecasted value of InMed Pharmaceuticals on the next trading day is expected to be 5.41 with a mean absolute deviation of 0.35 and the sum of the absolute errors of 21.35. InMed Stock Forecast is based on your current time horizon. Although InMed Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of InMed Pharmaceuticals' systematic risk associated with finding meaningful patterns of InMed Pharmaceuticals fundamentals over time.
InMed |
InMed Pharmaceuticals Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the InMed Pharmaceuticals' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2001-09-30 | Previous Quarter 6.6 M | Current Value 5.6 M | Quarterly Volatility 4.7 M |
InMed Pharmaceuticals Naive Prediction Price Forecast For the 16th of December 2024
Given 90 days horizon, the Naive Prediction forecasted value of InMed Pharmaceuticals on the next trading day is expected to be 5.41 with a mean absolute deviation of 0.35, mean absolute percentage error of 0.20, and the sum of the absolute errors of 21.35.Please note that although there have been many attempts to predict InMed Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that InMed Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
InMed Pharmaceuticals Stock Forecast Pattern
| Backtest InMed Pharmaceuticals | InMed Pharmaceuticals Price Prediction | Buy or Sell Advice |
InMed Pharmaceuticals Forecasted Value
In the context of forecasting InMed Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. InMed Pharmaceuticals' downside and upside margins for the forecasting period are 0.05 and 12.25, respectively. We have considered InMed Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of InMed Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent InMed Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.5176 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.35 |
| MAPE | Mean absolute percentage error | 0.0707 |
| SAE | Sum of the absolute errors | 21.3521 |
Predictive Modules for InMed Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as InMed Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for InMed Pharmaceuticals
For every potential investor in InMed, whether a beginner or expert, InMed Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. InMed Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in InMed. Basic forecasting techniques help filter out the noise by identifying InMed Pharmaceuticals' price trends.View InMed Pharmaceuticals Related Equities
| Risk & Return | Correlation |
InMed Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of InMed Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of InMed Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
InMed Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how InMed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading InMed Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying InMed Pharmaceuticals stock market strength indicators, traders can identify InMed Pharmaceuticals entry and exit signals to maximize returns.
InMed Pharmaceuticals Risk Indicators
The analysis of InMed Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in InMed Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting inmed stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.77 | |||
| Semi Deviation | 6.38 | |||
| Standard Deviation | 6.87 | |||
| Variance | 47.19 | |||
| Downside Variance | 46.5 | |||
| Semi Variance | 40.73 | |||
| Expected Short fall | (5.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of InMed Pharmaceuticals to cross-verify your projections. To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 230.4 | Revenue Per Share 0.603 | Quarterly Revenue Growth (0.45) | Return On Assets (0.39) | Return On Equity (0.72) |
The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if InMed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.